Trials of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, are documenting its direct kidney effects and broad benefits for diabetic kidney disease.
The editorial, "Dynamics-driven medical big data mining: dynamic approaches to early disease forecasting and individualized care," published in Intelligent Medicine (February 2026, Volume 6, Issue 1), ...
Pharmaceutical Technology on MSNOpinion
Advancing single-cell transcriptomics into the mainstream of biomedical research
Kelly Parliament, staff application scientist at Beckman Coulter Life Sciences, discusses how automation is improving the ...
Research into the genetic influence on lifespan suggests new approaches to preventative care and patient risk stratification.
Leveraging an AI-powered omnimodal foundation model to accelerate drug discovery, optimize patient stratification, and de-risk clinical developmentWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a ...
BACKGROUND: Preeclampsia affects approximately 1 in 10 pregnancies, leading to severe complications and long-term health ...
A novel glioblastoma therapy developed by Rosalind Franklin University Helix 51 incubator company UP Oncolytics showed encouraging preclinical results in two studies presented at the American ...
CDT holds a 20% equity interest in Sarborg and believes this development represents a meaningful extension of Sarborg’s proprietary Signature Intelligence platform beyond its initial pharmaceutical ...
Multifactorial diseases pose a significant global health challenge, impacting economically developed nations with conditions ...
Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich Leukemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results